标题
The mTOR pathway in hepatic malignancies
作者
关键词
-
出版物
HEPATOLOGY
Volume 58, Issue 2, Pages 810-818
出版商
Wiley
发表日期
2013-02-13
DOI
10.1002/hep.26323
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin Inhibits Growth of Hepatocellular Carcinoma Cells by Inducing Apoptosis Via Mitochondrion-mediated Pathway
- (2013) Yu Xiong et al. Asian Pacific Journal of Cancer Prevention
- Reprogramming of the MicroRNA Transcriptome Mediates Resistance to Rapamycin
- (2013) Hana Totary-Jain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma
- (2012) Li Cui et al. BMC CANCER
- Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
- (2012) K. Bhalla et al. Cancer Prevention Research
- eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
- (2012) T. Alain et al. CANCER RESEARCH
- Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma
- (2012) Thomas Decaens et al. DIGESTIVE AND LIVER DISEASE
- Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients
- (2012) Ferdinand Wagner et al. EUROPEAN JOURNAL OF CANCER
- Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development
- (2012) Kun Wu et al. HEPATOLOGY
- In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma
- (2012) Zhan Qu et al. HEPATOLOGY RESEARCH
- Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice
- (2012) S. Menon et al. Science Signaling
- mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinoma
- (2012) H. E. Thomas et al. Science Translational Medicine
- Thymosin-β4 (Tβ4) Blunts PDGF-Dependent Phosphorylation and Binding of AKT to Actin in Hepatic Stellate Cells
- (2011) Karina Reyes-Gordillo et al. AMERICAN JOURNAL OF PATHOLOGY
- Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence
- (2011) C. Toso et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Phase 1/2 study of everolimus in advanced hepatocellular carcinoma
- (2011) Andrew X. Zhu et al. CANCER
- mTOR complex 2 signaling and functions
- (2011) Won Jun Oh et al. CELL CYCLE
- Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin αVβ3 engagement and PI3K/pAkt/NFκB signaling
- (2011) Raquel Urtasun et al. HEPATOLOGY
- l-Tryptophan-mediated Enhancement of Susceptibility to Nonalcoholic Fatty Liver Disease Is Dependent on the Mammalian Target of Rapamycin
- (2011) Yosuke Osawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- m-TOR inhibitors: What role in liver transplantation?
- (2011) Toshiyasu Kawahara et al. JOURNAL OF HEPATOLOGY
- Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo
- (2011) Huanjie Shao et al. JOURNAL OF HEPATOLOGY
- PKI-587 and Sorafenib Targeting PI3K/AKT/mTOR and Ras/Raf/MAPK Pathways Synergistically Inhibit HCC Cell Proliferation
- (2011) Roberto Gedaly et al. JOURNAL OF SURGICAL RESEARCH
- Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
- (2011) Wenhua Liang et al. LIVER TRANSPLANTATION
- Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
- (2011) Carlos Gomez-Martin et al. LIVER TRANSPLANTATION
- The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas
- (2011) Dakeun Lee et al. MODERN PATHOLOGY
- Rapamycin passes the torch: a new generation of mTOR inhibitors
- (2011) Don Benjamin et al. NATURE REVIEWS DRUG DISCOVERY
- Common toxicities of mammalian target of rapamycin inhibitors
- (2011) Scott A. Soefje et al. Targeted Oncology
- Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma
- (2011) Siobhan C. McKay et al. HPB
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis
- (2010) Nuria Martínez-López et al. HEPATOLOGY
- Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis
- (2010) Eleonora Patsenker et al. JOURNAL OF HEPATOLOGY
- Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
- (2010) Valter Donadon et al. LIVER INTERNATIONAL
- Activation of Phosphatidylinositol-3'-kinase/AKT Signaling Is Essential in Hepatoblastoma Survival
- (2009) W. Hartmann et al. CLINICAL CANCER RESEARCH
- The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic Cholangiocarcinoma
- (2009) J.-Y. Chung et al. CLINICAL CANCER RESEARCH
- S6K1 deficiency protects against apoptosis in hepatocytes
- (2009) Águeda González-Rodriguez et al. HEPATOLOGY
- Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage
- (2009) Laura Elisa Buitrago-Molina et al. HEPATOLOGY
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- miR-221 overexpression contributes to liver tumorigenesis
- (2009) P. Pineau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth
- (2008) Thomas Porstmann et al. Cell Metabolism
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation
- (2008) Sanae Haga et al. HEPATOLOGY
- Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
- (2008) Magnus Rizell et al. International Journal of Clinical Oncology
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now